Early Diagnosis of Neonatal Septicemia: Current Status and Prospects of Inflammatory Markers and Detection Technologies

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Review summarizes the role of inflammatory biomarkers and detection methods in neonatal sepsis, indicating key advancements.

Improved early diagnosis of neonatal sepsis can enhance patient outcomes, as effective treatment is critical.
Inflammatory biomarkers like IL-6, CRP, and PCT show promise in diagnosing early-onset sepsis, enhancing accuracy.
Novel detection methods, including PCR and POCT, speed up diagnosis but require further clinical validation for effectiveness.
Standardization of testing procedures is essential to ensure the reliability and comparability of diagnostic results.

Jiang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark